"The breakthrough has excited researchers" because the allergy drug found to kill the malaria parasite is "already licensed for use in people," and because it is "no longer under patent, it will be possible to manufacture it at rock-bottom prices." … The drug could save 1 million children in sub-Saharan Africa every year. (The Guardian)
